AG˹ٷ

STOCK TITAN

[Form 4] UNITEDHEALTH GROUP INCORPORATED (Delaware) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

UnitedHealth Group Inc. (UNH) filed a Form 4 reporting a routine ownership update for Christopher R. Zaetta, EVP & Chief Legal Officer. On 06/24/2025, Zaetta acquired 48.038 common shares at a stated price of $0, representing dividend-equivalent units credited on outstanding restricted stock units (RSUs). These dividend equivalents carry the same vesting conditions as the underlying RSUs and are forfeited if those units fail to vest. Following the credit, Zaetta’s direct beneficial ownership stands at 10,240.746 shares. No derivatives were reported, and there were no dispositions of shares.

UnitedHealth Group Inc. (UNH) ha presentato un modulo Form 4 per comunicare un aggiornamento ordinario della proprietà azionaria di Christopher R. Zaetta, EVP e Chief Legal Officer. Il 24/06/2025, Zaetta ha acquisito 48.038 azioni ordinarie a un prezzo dichiarato di $0, rappresentanti unità equivalenti ai dividendi accreditate su azioni vincolate (RSU) in essere. Queste unità equivalenti ai dividendi sono soggette alle stesse condizioni di maturazione delle RSU sottostanti e vengono perse se tali azioni non maturano. Dopo questo accredito, la proprietà beneficiaria diretta di Zaetta ammonta a 10.240,746 azioni. Non sono stati segnalati derivati né cessioni di azioni.

UnitedHealth Group Inc. (UNH) presentó un Formulario 4 reportando una actualización rutinaria de propiedad para Christopher R. Zaetta, EVP y Chief Legal Officer. El 24/06/2025, Zaetta adquirió 48.038 acciones ordinarias a un precio declarado de $0, representando unidades equivalentes a dividendos acreditadas sobre unidades restringidas de acciones (RSU) en circulación. Estas unidades equivalentes a dividendos tienen las mismas condiciones de adquisición que las RSU subyacentes y se pierden si esas unidades no se adquieren. Tras este crédito, la propiedad beneficiaria directa de Zaetta es de 10,240.746 acciones. No se reportaron derivados ni disposiciones de acciones.

UnitedHealth Group Inc. (UNH)� Christopher R. Zaetta, EVP � 최고법률책임�� 소유� 정기 업데이트� 보고하는 Form 4� 제출했습니다. 2025� 6� 24�, Zaetta� $0� 명시� 가격으� 48,038주의 보통�� 취득했으�, 이는 미결 제한 주식 단위(RSU)� 대� 적립� 배당� 등가 단위입니�. � 배당� 등가 단위� 기초 RSU와 동일� 취득 조건� 가지�, 해당 단위가 취득되지 않으� 몰수됩니�. � 적립 � Zaetta� 직Ϊ 실소� 주식은 10,240.746�입니�. 파생상품은 보고되지 않았으며 주식 처분� 없었습니�.

UnitedHealth Group Inc. (UNH) a déposé un formulaire 4 signalant une mise à jour de routine de la propriété pour Christopher R. Zaetta, EVP et Chief Legal Officer. Le 24/06/2025, Zaetta a acquis 48 038 actions ordinaires à un prix déclaré de 0 $, représentant des unités équivalentes aux dividendes créditées sur des unités d’actions restreintes (RSU) en circulation. Ces équivalents dividendes sont soumis aux mêmes conditions d’acquisition que les RSU sous-jacentes et sont perdus si ces unités ne sont pas acquises. Suite à ce crédit, la propriété bénéficiaire directe de Zaetta s’élève à 10 240,746 actions. Aucun dérivé n’a été déclaré et aucune cession d’actions n’a eu lieu.

UnitedHealth Group Inc. (UNH) reichte ein Formular 4 ein, um ein routinemäßiges Eigentumsupdate für Christopher R. Zaetta, EVP & Chief Legal Officer, zu melden. Am 24.06.2025 erwarb Zaetta 48.038 Stammaktien zu einem angegebenen Preis von $0, was Dividendenäquivalent-Einheiten entspricht, die auf ausstehenden Restricted Stock Units (RSUs) gutgeschrieben wurden. Diese Dividendenäquivalente unterliegen den gleichen Vesting-Bedingungen wie die zugrundeliegenden RSUs und verfallen, wenn diese Einheiten nicht vesten. Nach der Gutschrift beträgt Zaettas direkter wirtschaftlicher Eigentumsanteil 10.240,746 Aktien. Es wurden keine Derivate gemeldet und keine Aktien veräußert.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Minor dividend-equivalent share credit; routine update, negligible financial impact, but maintains insider alignment.

The filing documents an automatic credit of 48.038 dividend-equivalent shares to EVP & CLO Christopher Zaetta. Such credits are customary and non-cash; they neither signal active buying nor materially change the insider’s exposure (increase of <�0.5%> relative to his 10.2 k-share stake). For a company of UnitedHealth’s scale, the transaction is immaterial to valuation or liquidity. It nonetheless reaffirms that unvested RSUs accrue dividends, aligning executive incentives with shareholder returns. No red flags—no sales, no derivative exercises, and no 10b5-1 plan disclosure—indicate neutral impact on near-term market perception.

UnitedHealth Group Inc. (UNH) ha presentato un modulo Form 4 per comunicare un aggiornamento ordinario della proprietà azionaria di Christopher R. Zaetta, EVP e Chief Legal Officer. Il 24/06/2025, Zaetta ha acquisito 48.038 azioni ordinarie a un prezzo dichiarato di $0, rappresentanti unità equivalenti ai dividendi accreditate su azioni vincolate (RSU) in essere. Queste unità equivalenti ai dividendi sono soggette alle stesse condizioni di maturazione delle RSU sottostanti e vengono perse se tali azioni non maturano. Dopo questo accredito, la proprietà beneficiaria diretta di Zaetta ammonta a 10.240,746 azioni. Non sono stati segnalati derivati né cessioni di azioni.

UnitedHealth Group Inc. (UNH) presentó un Formulario 4 reportando una actualización rutinaria de propiedad para Christopher R. Zaetta, EVP y Chief Legal Officer. El 24/06/2025, Zaetta adquirió 48.038 acciones ordinarias a un precio declarado de $0, representando unidades equivalentes a dividendos acreditadas sobre unidades restringidas de acciones (RSU) en circulación. Estas unidades equivalentes a dividendos tienen las mismas condiciones de adquisición que las RSU subyacentes y se pierden si esas unidades no se adquieren. Tras este crédito, la propiedad beneficiaria directa de Zaetta es de 10,240.746 acciones. No se reportaron derivados ni disposiciones de acciones.

UnitedHealth Group Inc. (UNH)� Christopher R. Zaetta, EVP � 최고법률책임�� 소유� 정기 업데이트� 보고하는 Form 4� 제출했습니다. 2025� 6� 24�, Zaetta� $0� 명시� 가격으� 48,038주의 보통�� 취득했으�, 이는 미결 제한 주식 단위(RSU)� 대� 적립� 배당� 등가 단위입니�. � 배당� 등가 단위� 기초 RSU와 동일� 취득 조건� 가지�, 해당 단위가 취득되지 않으� 몰수됩니�. � 적립 � Zaetta� 직Ϊ 실소� 주식은 10,240.746�입니�. 파생상품은 보고되지 않았으며 주식 처분� 없었습니�.

UnitedHealth Group Inc. (UNH) a déposé un formulaire 4 signalant une mise à jour de routine de la propriété pour Christopher R. Zaetta, EVP et Chief Legal Officer. Le 24/06/2025, Zaetta a acquis 48 038 actions ordinaires à un prix déclaré de 0 $, représentant des unités équivalentes aux dividendes créditées sur des unités d’actions restreintes (RSU) en circulation. Ces équivalents dividendes sont soumis aux mêmes conditions d’acquisition que les RSU sous-jacentes et sont perdus si ces unités ne sont pas acquises. Suite à ce crédit, la propriété bénéficiaire directe de Zaetta s’élève à 10 240,746 actions. Aucun dérivé n’a été déclaré et aucune cession d’actions n’a eu lieu.

UnitedHealth Group Inc. (UNH) reichte ein Formular 4 ein, um ein routinemäßiges Eigentumsupdate für Christopher R. Zaetta, EVP & Chief Legal Officer, zu melden. Am 24.06.2025 erwarb Zaetta 48.038 Stammaktien zu einem angegebenen Preis von $0, was Dividendenäquivalent-Einheiten entspricht, die auf ausstehenden Restricted Stock Units (RSUs) gutgeschrieben wurden. Diese Dividendenäquivalente unterliegen den gleichen Vesting-Bedingungen wie die zugrundeliegenden RSUs und verfallen, wenn diese Einheiten nicht vesten. Nach der Gutschrift beträgt Zaettas direkter wirtschaftlicher Eigentumsanteil 10.240,746 Aktien. Es wurden keine Derivate gemeldet und keine Aktien veräußert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zaetta Christopher R

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 A 48.038(1) A $0 10,240.746 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Christopher R. Zaetta 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christopher R. Zaetta report in the 06/24/2025 Form 4 for UNH?

He reported the acquisition of 48.038 dividend-equivalent common shares credited to his account.

How many UnitedHealth Group (UNH) shares does Zaetta own after the transaction?

After the credit, he directly owns 10,240.746 common shares.

What was the price of the shares acquired by Zaetta?

The dividend-equivalent shares were recorded at $0 cost, reflecting a non-cash credit.

Were any derivative securities involved in this Form 4 filing?

No derivative securities were acquired or disposed of in the reported transaction.

Did the filing indicate the use of a Rule 10b5-1 trading plan?

The filing does not state that the transaction was executed under a Rule 10b5-1 plan.
Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

246.17B
904.48M
0.27%
90.58%
1.4%
Healthcare Plans
Hospital & Medical Service Plans
United States
EDEN PRAIRIE